MedTrace Logo

Acupuncture for Chemical Therapy Induced Nausea and Vomiting

NCT02842307 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2016-07-22

No results posted yet for this study

Summary

This is an expertise-based randomized controlled trial. The hypothesis of this study is that the differences in expertise of acupuncturist may impact clinical effect. In this study, patients will be randomized to 4 group, receiving the treatment from senior acupuncturist, junior acupuncturist, junior acupuncturist by only acupuncture Neiguan(P6), or not receive the acupuncture. All patients receive the basic cisplatin chemotherapy. The duration of treatment is from the first day receiving cisplatin until two days after cisplatin on each group. NCI and Rhode scale will be used to measure the control of nausea and vomiting.

Conditions

  • Chemotherapy-induced Nausea and Vomiting

Interventions

PROCEDURE

Manual acupuncture implemented by senior acupuncturists

Manual acupuncture once per day. No limitation on points, manipulations and time per session. Senior acupuncturists have to have more than 15 years of acupuncture clinical practice experience.

PROCEDURE

Manual acupuncture implemented by junior acupuncturists

Manual acupuncture once per day. No limitation on points, manipulations and time per session. Junior acupuncturists have to have less than 5 years of acupuncture clinical practice experience.

PROCEDURE

Manual acupuncture on P6 point

Manual acupuncture implemented by junior acupuncturists once per day. P6 point, bilaterally, should achieve deqi sensation by even manipulations. Junior acupuncturists have to have less than 5 years of acupuncture clinical practice experience.

Sponsors & Collaborators

  • Dongzhimen Hospital, Beijing

    collaborator OTHER

  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    collaborator OTHER

  • Xiyuan Hospital of China Academy of Chinese Medical Sciences

    collaborator OTHER

  • Beijing University of Chinese Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02842307 on ClinicalTrials.gov